ESNEFT Neuroendocrine Tumours (NET) Multi-Disciplinary Team

Providing specialist, world-class care and innovative molecular therapies for patients across Essex and Suffolk.

ESNEFT is the regional based at Colchester hospital, serving patients locally in North Essex and Suffolk while partnerships with Mid Essex and Southend serves patients in those areas .

Since 2024 we have been offering Lutetium-177 (Lu) radiotherapy  which is a targeted molecular therapy (PRRT ) for advanced neuroendocrine tumours not responding to first line therapy with somatostatin analogues (lanreotide and sandostatin LAR).